The effect of trans sodium crocetinate (TSC) in a rat oleic acid model of acute lung injury.
Pulm Pharmacol Ther
; 18(3): 213-6, 2005.
Article
en En
| MEDLINE
| ID: mdl-15707856
ABSTRACT
Trans sodium crocetinate is a novel drug, which has been shown previously to increase whole-body oxygen consumption during hemorrhagic shock. TSC has been suggested to work by increasing the diffusion rate of oxygen through plasma rather than on a specific symptom of hemorrhagic shock and has been suggested as a general treatment for hypoxemia. Thus, it might also be beneficial for treating respiratory insufficiencies. This study employed an oleic acid model of acute lung injury to determine if TSC could increase arterial PO2 in that model.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Síndrome de Dificultad Respiratoria
/
Carotenoides
/
Antioxidantes
Límite:
Animals
Idioma:
En
Revista:
Pulm Pharmacol Ther
Asunto de la revista:
FARMACOLOGIA
Año:
2005
Tipo del documento:
Article
País de afiliación:
Estados Unidos